
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $82.3M | -- | -- | $0.38 | -- |
08/11/2025 | Q2 | $81.7M | -- | -- | $0.38 | -- |
05/12/2025 | Q1 | $82.5M | $31.8M | $0.32 | $0.38 | -$0.06 |
02/25/2025 | Q4 | $86.3M | $26.6M | $0.24 | $0.40 | -$0.16 |
11/07/2024 | Q3 | $79.9M | $29.8M | $0.31 | $0.42 | -$0.11 |
08/07/2024 | Q2 | $70.7M | $25.2M | $0.35 | $0.43 | -$0.08 |
05/07/2024 | Q1 | $69.9M | $28.7M | $0.39 | $0.43 | -$0.04 |
02/26/2024 | Q4 | $67.7M | $37.6M | $0.51 | $0.43 | $0.08 |
11/07/2023 | Q3 | -- | -- | $0.46 | $0.44 | $0.02 |
08/02/2023 | Q2 | -- | -- | $0.39 | $0.44 | -$0.05 |
05/02/2023 | Q1 | -- | -- | $0.46 | $0.42 | $0.04 |
02/21/2023 | Q4 | -- | -- | $0.02 | -- | -- |
11/03/2022 | Q3 | -- | -- | $0.25 | -- | -- |
08/04/2022 | Q2 | -- | -- | $0.09 | -- | -- |
03/31/2022 | Q1 | -- | -- | $0.07 | -- | -- |
12/31/2021 | Q4 | -- | -- | $0.32 | $0.34 | -$0.02 |
09/30/2021 | Q3 | -- | -- | $0.39 | $0.35 | $0.04 |
06/30/2021 | Q2 | -- | -- | $0.49 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.65 | -- | -- |
12/31/2020 | Q4 | -- | -- | $0.51 | -- | -- |
09/30/2020 | Q3 | -- | -- | $0.51 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.05 | -- | -- |
03/31/2020 | Q1 | -- | -- | -$2.22 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.00 | -- | -- |
09/30/2019 | Q3 | -- | -- | $0.10 | -- | -- |
06/30/2019 | Q2 | -- | -- | $0.35 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.46 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$0.02 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.39 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.18 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.30 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.08 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.42 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.39 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.10 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.15 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.54 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.57 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.31 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.33 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.03 | -- | -- |
MidCap Financial Investment reported $31.8M worth of top line sales in its most recent quarter.
MidCap Financial Investment announced earnings per share of $0.32 which represents a miss of analyst forecast a $0.38 per share.
MidCap Financial Investment reported -- that represents -- per share over the last quarter.
MidCap Financial Investment's earnings are forecast to grow from $1.27 per share to $1.72 per share next year representing an increase of 18.51%.
MidCap Financial Investment's next earnings date is August 11, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.